NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma
Clinical trial NCT03549715 · UNKNOWN
Trial details
- NCT number
- NCT03549715
- Sponsor
- Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2024-06-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.